Posted 17 April 2025, 1:21 am EST
Temozolomide is an oral chemotherapy drug primarily used to treat glioblastoma multiforme and other types of brain tumors. It works by damaging the DNA of cancer cells, preventing them from multiplying. Temozolomide is often prescribed alongside radiation therapy and has become a cornerstone in the management of aggressive brain cancers due to its effectiveness and ability to cross the blood-brain barrier. Its oral administration also makes it more convenient for patients compared to intravenous chemotherapy.
With the growing demand for affordable cancer treatments, Temozolomide manufacturers in India have emerged as key global suppliers, providing high-quality generic versions of the drug. Their role is crucial in ensuring wider accessibility and supporting oncology care in both developed and developing countries.
